Q3 EPS consensus $3.27.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- AbbVie price target raised to $251 from $220 at BofA
- AbbVie’s Phase 2 HIV Study Completion: Potential Market Impact
- AbbVie Completes Key Study on ABBV-101’s Food Interaction
- AbbVie downgraded to Hold from Buy at HSBC (yesterday)